ALKS vs NWS · P/E 14, rev $1.56B vs rev $9.03B
Alkermes Plc (ALKS) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
NWS (NWS) common stock.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. NWS currently screens at market cap $0.
Not investment advice. Open the ALKS and NWS stock pages for the full models.
Not investment advice.